In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

NeuroSearch spins out Sophion Bioscience, raises $7.9mm

Executive Summary

Nervous system therapeutics researcher and developer NeuroSearch AS has spun out a new company, Sophion Bioscience, which will focus on screening systems for drug discovery. It has raised $7.9mm (DKK67.4mm) through investors Medicon Valley Capital, Dansk Erhvervsinvestering AS, Dansk Kapitalanlaeg AB, and Baker-Tisch. NeuroSearch will have a 32% stake in the company; the investors 64%, and Sophion and NeuroSearch employees will hold the remainder.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Drug Discovery Tools
      • Bioinformatics
      • Molecular Diversity
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies